Difference between revisions of "Template:Current week ecosystem agenda"
From Bioblast
Tindle Lisa (talk | contribs) |
Cocco Paolo (talk | contribs) |
||
Line 1: | Line 1: | ||
2021 Week | 2021 Week 10 | ||
*'''Mar-08 Mo''' | |||
:::: Abstract submission deadline for: »[[ESCI 2021 Virtual]]« | |||
---- | |||
*'''Mar-09 Tu''' - [[12th_%C3%96GMBT_Annual_Meeting_2020_Virtual_Event#Programme|ÖGMBT Life Science Tuesdays]] | |||
*'''Mar- | ---- | ||
*'''Mar-10 We''' | |||
:{| | :{| | ||
| width="100" align="center" |[[ | | width="100" align="center" |[[File:MitoFit Preprints pdf.png|100px|link=https://www.mitofit.org/index.php/Krako_Jakovljevic_2021_MitoFit_PD |MitoFit pdf]] | ||
|''' | |'''Mitochondrial physiology in Parkinson’s disease (PD)'''<br> | ||
A [[MitoEAGLE|COST Action MitoEAGLE]] contribution:<br> | |||
* | * Krako Jakovljevic N, Ebanks B, Chakrabarti L, Markovic I, Moisoi N (2021) Mitochondrial homeostasis in cellular models of Parkinson’s Disease. MitoFit Preprints 2021.4 [https://www.mitofit.org/index.php/Krako_Jakovljevic_2021_MitoFit_PD doi:10.26124/mitofit:2021-0004] | ||
|} | |} | ||
---- | ---- | ||
*'''Mar- | *'''Mar-11 Th''' | ||
:{| | :{| | ||
| width="110" align="center" | [[File: | | width="110" align="center" | [[File:Gnaiger 2020 BEC MitoPathways.jpg|70px|link=https://www.bioenergetics-communications.org/index.php/bec/article/view/gnaiger_2020_mitopathways|Gnaiger 2020 BEC MitoPathways]] | ||
|''' | | '''Internal normalization of rate – what is the difference between ''flux control ratio'' and ''flux control efficiency''?'''<br> | ||
A ''flux control ratio'' is the ratio of oxygen flux in a specific respiratory control state, normalized for maximum flux in a common reference state. ''Flux control efficiency'' expresses the control of respiration as a fractional change of oxygen flux or flow between protocol steps. Both values vary between theoretical lower and upper limits of 0 and 1. <br> | |||
- » | - »[https://www.bioenergetics-communications.org/index.php/bec/article/view/gnaiger_2020_mitopathways Gnaiger 2020 BEC MitoPathways - Chapter 3]« <br> | ||
- | - » Posted by: »[[Komlodi Timea]]« and »[[Cecatto Cristiane]]« | ||
|} | |} | ||
---- | ---- | ||
*'''Mar- | *'''Mar-12 Fr''' |
Revision as of 12:38, 8 March 2021
2021 Week 10
- Mar-08 Mo
- Abstract submission deadline for: »ESCI 2021 Virtual«
- Mar-09 Tu - ÖGMBT Life Science Tuesdays
- Mar-10 We
Mitochondrial physiology in Parkinson’s disease (PD)
A COST Action MitoEAGLE contribution:
- Krako Jakovljevic N, Ebanks B, Chakrabarti L, Markovic I, Moisoi N (2021) Mitochondrial homeostasis in cellular models of Parkinson’s Disease. MitoFit Preprints 2021.4 doi:10.26124/mitofit:2021-0004
- Mar-11 Th
Internal normalization of rate – what is the difference between flux control ratio and flux control efficiency?
A flux control ratio is the ratio of oxygen flux in a specific respiratory control state, normalized for maximum flux in a common reference state. Flux control efficiency expresses the control of respiration as a fractional change of oxygen flux or flow between protocol steps. Both values vary between theoretical lower and upper limits of 0 and 1.
- »Gnaiger 2020 BEC MitoPathways - Chapter 3«
- » Posted by: »Komlodi Timea« and »Cecatto Cristiane«
- Mar-12 Fr